These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17105835)

  • 61. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
    Salerno D; Vahid B; Marik PE
    Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Bodmann KF
    Pharm Unserer Zeit; 2004; 33(1):38-41. PubMed ID: 14968711
    [No Abstract]   [Full Text] [Related]  

  • 66. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.
    Gebhart BC; Barker BC; Markewitz BA
    Pharmacotherapy; 2007 Mar; 27(3):476-9. PubMed ID: 17316160
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Linezolid as rescue drug: a clinical case of soft tissue infection caused by a Staphylococcus aureus strain resistant in vivo to teicoplanin.
    Testore GP; Natoli S; Fontana C; Buonuomini AR; Leonardi L; Leonardis F
    J Chemother; 2006 Aug; 18(4):430-2. PubMed ID: 17024801
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Linezolid for the treatment of drug-resistant infections.
    Herrmann DJ; Peppard WJ; Ledeboer NA; Theesfeld ML; Weigelt JA; Buechel BJ
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):825-48. PubMed ID: 19053895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 75. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expensive modern therapy options in intensive care medicine in Germany-- are they being used? Results of a questionnaire].
    Boldt J; Papsdorf M
    Dtsch Med Wochenschr; 2005 Jan; 130(3):87-91. PubMed ID: 15650957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of antibiotics on methicillin-resistant Staphylococcus aureus.
    Dancer SJ
    J Antimicrob Chemother; 2008 Feb; 61(2):246-53. PubMed ID: 18057071
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
    Isaacson G; Aronoff SC
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):647-51. PubMed ID: 18321598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.
    Stevens DL; Wallace RJ; Hamilton SM; Bryant AE
    Clin Infect Dis; 2006 Mar; 42(5):729-30. PubMed ID: 16447124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.